Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Tipo de estudio
Tipo del documento
Publication year range
1.
Rev Assoc Med Bras (1992) ; 67Suppl 1(Suppl 1): 18-21, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34259775

RESUMEN

COVID-19 infection is more severe in patients with type 2 diabetes mellitus (DM2). The severity of this viral infection is associated with an intense inflammatory activity. DM2 is a disease that also determines a greater degree of systemic inflammation. This is due to hyperglycemia, the higher prevalence of sleep disorders and also the low levels of melatonin, a substance with anti-inflammatory actions, in these patients. In this article, we suggest that exogenous melatonin may have an important anti-inflammatory role in preventing severe forms of COVID -19 in patients with DM2.


Asunto(s)
COVID-19 , Diabetes Mellitus Tipo 2 , Hiperglucemia , Melatonina , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Humanos , Melatonina/uso terapéutico , SARS-CoV-2
2.
Case Rep Endocrinol ; 2017: 8541078, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28270939

RESUMEN

Thyroglossal duct cyst (TDC) is a cystic expansion of a remnant of the thyroglossal duct tract. Carcinomas in the TDC are extremely rare and are usually an incidental finding after the Sistrunk procedure. In this report, an unusual case of a 36-year-old woman with concurrent papillary thyroid carcinoma arising in the TDC and on the thyroid gland is presented, followed by a discussion of the controversies surrounding the possible origins of a papillary carcinoma in the TDC, as well as the current management options.

3.
Rev. Assoc. Med. Bras. (1992, Impr.) ; 67(supl.1): 18-21, 2021.
Artículo en Inglés | LILACS | ID: biblio-1287838

RESUMEN

SUMMARY COVID-19 infection is more severe in patients with type 2 diabetes mellitus (DM2). The severity of this viral infection is associated with an intense inflammatory activity. DM2 is a disease that also determines a greater degree of systemic inflammation. This is due to hyperglycemia, the higher prevalence of sleep disorders and also the low levels of melatonin, a substance with anti-inflammatory actions, in these patients. In this article, we suggest that exogenous melatonin may have an important anti-inflammatory role in preventing severe forms of COVID -19 in patients with DM2.


Asunto(s)
Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , COVID-19 , Hiperglucemia , SARS-CoV-2 , Melatonina/uso terapéutico
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda